Takeda
Scope
Date
~
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion puts Takeda’s assets up for sale after 3 years
South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...
Jun 18, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion finalizes $278mn acquisition of Takeda's primary care assets
South Korea's biopharmaceutical firm Celltrion Inc. has completed the $278 million acquisition of Takeda Pharmaceutical Company Ltd's primary care a...
Dec 01, 2020 (Gmt+09:00)
Latest News
- 1 Macquarie Korea Asset Management confirms two nominees
- 2 Overseas Korean food fans choose soju, bibimbap as favorites
- 3 Beauty store chain CJ Olive Young to launch Japan unit
- 4 Samsung hits highest US smartphone market share in 4 years
- 5 Shinhan, POSCO invest $20 mn in Australian hydrogen firm Hysata